Therapeutic Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Althea Medical Journal, v. 12, n. 3, p. 161–171, 30 Sep.2025.